PUBCHEM ID | 30247 |
Molecular Weight (g/mol) | 196.286 |
Molecular Formula | C12H20O2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 6 |
IUPAC Name | (5-methyl-2-prop-1-en-2-ylhex-4-enyl) acetate |
Canonical SMILES | C=C(C)C(C/C=C(C)/C)COC(C)=O |
PUBCHEM IUPAC INCHIKEY | HYNGAVZPWWXQIU-UHFFFAOYSA-N |
Solubility Level | 3 |
Vapour Pressure | -1.376 |
XLOGP3 AA | 3.6 |
CACTVS TPSA | 26.3 |
BBB Level | 1 |
Absorption Level | 0 |
EXT PPB#Prediction | 1 |
AlogP98 | 3.095 |
EXT CYP2D6#Prediction | 0 |
Mouse Female FDA | Non-Carcinogen |
Mouse Male FDA | Multi-Carcinogen |
Rat Female FDA | Single-Carcinogen |
Rat Male FDA | Single-Carcinogen |
Ames Prediction | Non-Mutagen |
Developmental / Reproductive Toxicity | Non-Toxic |
Rat Oral LD50 | 3.33646 g/kg_body_weight |
Ocular Irritancy | None |
Hepatotoxic#Prediction | 0 |
Effected Human Genes |
Aerobic Biodegradability Prediction | Degradable |
Physical hazards | not classified |
Health hazards | Moderate |
Environmental hazards | not classified |
Serial No. | Cas No | Gene Symbol | Organism | Interaction | Interaction Actions | PubMed Id |
---|---|---|---|---|---|---|
1 | 25905-14-0 |
Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
---|---|---|---|---|---|
1 | 25905-14-0 | Lavandulyl Acetate |
Serial No. | Plant Name | Variety Name | Essential Oil | Compound Percentage |
---|---|---|---|---|
1 | Lavendula angustifolia | Sher-e-Kashmir | Lavandula angustifolia sher-e-Kashmir essential oil | |
2 | Broadleaved lavender, spike lavender or Portuguese lavender | Lavandula latifolia essential oil |